[Clinical experience on aztreonam]. 1985

K Seki, and H Nakamura, and Y Iwata, and S Hayashi

Aztreonam (AZT), a new monobactam antibiotic, was studied for clinical efficacy in the field of gynecologic infection. AZT was administered at a daily dose of 2 g in 2 divided doses by single shot intravenous injection. The subjects were patients with the following infections: adnexitis (6), pelvic peritonitis (5), endometritis (1) and wound abscess (1). Good response was seen in 10 patients out of 13. The overall efficacy rate of 76.9% was obtained. Slight increase in GOT, GPT and Al-P was seen in 1 case. It was normalized on 6th day after completion of the therapy. No notable side effects were observed.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005831 Genital Diseases, Female Pathological processes involving the female reproductive tract (GENITALIA, FEMALE). Gynecologic Diseases,Female Genital Diseases,Diseases, Female Genital,Diseases, Gynecologic,Female Genital Disease,Genital Disease, Female,Gynecologic Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001398 Aztreonam A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms. Az-threonam,Azactam,Azthreonam,SQ-26,776,Urobactam,Az threonam,SQ 26,776,SQ26,776
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases

Related Publications

K Seki, and H Nakamura, and Y Iwata, and S Hayashi
September 1989, The Pediatric infectious disease journal,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
November 1985, The Japanese journal of antibiotics,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
January 1986, New Jersey medicine : the journal of the Medical Society of New Jersey,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
January 1985, Reviews of infectious diseases,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
January 1985, Reviews of infectious diseases,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
June 1987, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
January 1991, Reviews of infectious diseases,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
January 1984, Current medical research and opinion,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
November 1985, The Japanese journal of antibiotics,
K Seki, and H Nakamura, and Y Iwata, and S Hayashi
December 1985, The Japanese journal of antibiotics,
Copied contents to your clipboard!